Emerging Healthcare Solutions Inc. hepatic, gene/cell therapy news

Emerging Healthcare Solutions and its Celulas Genetica wholly owned subsidiary will form a JV to develop and commercialize the Rutherford Procedure to treat liver disease. The procedure uses proton-be...